Hematology

The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The FDA has approved the first treatment for eosinophilic esophagitis.

The FDA has approved the first treatment for eosinophilic esophagitis.

A new treatment option for the management of blood sugar in individuals with type 2 diabetes is approved under FDA priority review designation.

A new treatment option for the management of blood sugar in individuals with type 2 diabetes is approved under FDA priority review designation.

The US Food and Drug Administration has approved a new medication therapy for the treatment of metastatic and unresectable melanoma.